Paul Bremer

Paul Bremer is an experienced researcher in the field of medicinal chemistry and immunotherapeutics, currently serving as the R&D Director at Cessation Therapeutics, Inc. since 2018. Bremer has held various positions at The Scripps Research Institute since 2011, including Professional Scientific Collaborator, Postdoctoral Researcher, and Graduate Student. Prior experience includes a role as Temporary Research Scientist in Medicinal Chemistry at Vertex Pharmaceuticals, along with several undergraduate research positions at institutions such as Colgate University, the National Institute of Allergy and Infectious Diseases, and the University of Minnesota. Bremer earned a Ph.D. in Medicinal Chemistry / Immunotherapeutics from Scripps Research and a Bachelor of Arts in Chemistry from Colgate University.